Iovance Biotherapeutics I... (IOVA)

NASDAQ: IOVA · Real-Time Price · USD

3.35

-0.24 (-6.69%)

At close: May 01, 2025, 3:59 PM

3.35

-0.15%

After-hours: May 01, 2025, 07:57 PM EDT

Iovance Biotherapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	164.07M	1.19M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	124M	10.76M	21.14M	13.98M	8.71M	8.12M	956K	952K	978K
Gross Profit	40.08M	-9.57M	-21.14M	-13.98M	-8.71M	-8.12M	-956K	-952K	-978K
Operating Income	-395.28M	-460.56M	-398.88M	-342.7M	-261.94M	-206.87M	-128.26M	-92.88M	-53.64M
Interest Income	20.27M	13.04M	2.98M	451K	2.36M	9.32M	n/a	813K	745K
Pretax Income	-375M	-447.52M	-395.89M	-342.25M	-259.58M	-197.56M	-123.58M	-92.06M	-52.89M
Net Income	-372.18M	-444.04M	-389.92M	-327.82M	-257.23M	-187.07M	-123.58M	-92.06M	-52.89M
Selling & General & Admin	153.02M	106.92M	104.1M	83.66M	60.21M	40.85M	28.43M	21.26M	25.6M
Research & Development	282.34M	344.08M	294.78M	259.04M	201.73M	166.02M	99.83M	71.61M	28.04M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	435.35M	450.99M	398.88M	342.7M	261.94M	206.87M	128.26M	92.88M	53.64M
Interest Expense	n/a	n/a	2.98M	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	79.22M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	559.35M	461.75M	398.88M	342.7M	261.94M	206.87M	128.26M	92.88M	53.64M
Income Tax Expense	-2.83M	-3.48M	-5.97M	-14.43M	-2.36M	-10.48M	4.68M	-952K	-978K
Shares Outstanding (Basic)	289.88M	235.13M	159.26M	153.41M	138.3M	124.34M	97.28M	65.24M	55.27M
Shares Outstanding (Diluted)	289.88M	235.13M	159.26M	153.41M	138.3M	124.34M	97.28M	65.24M	55.27M
EPS (Basic)	-1.28	-1.89	-2.45	-2.14	-1.86	-1.5	-1.27	-1.41	-0.96
EPS (Diluted)	-1.28	-1.89	-2.45	-2.14	-1.86	-1.5	-1.27	-1.41	-0.96
EBITDA	-351.67M	-427.43M	-374.76M	-328.27M	-250.87M	-189.43M	-122.62M	-91.11M	-51.92M
EBIT	-395.28M	-460.56M	-395.89M	-342.25M	-259.58M	-197.56M	-123.58M	-92.06M	-52.89M
Depreciation & Amortization	43.61M	33.13M	21.14M	13.98M	8.71M	8.12M	956K	952K	978K